MedPath

Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia

Not Applicable
Completed
Conditions
Lower Urinary Tract Symptoms
Benign Prostatic Hyperplasia
Interventions
Procedure: photoselective vaporization prostatectomy (PVP)
Procedure: Transurethral resection of the prostate
Registration Number
NCT00908427
Lead Sponsor
Samsung Medical Center
Brief Summary

The purpose of this study is to compared the efficacy of 80W KTP photoselective laser vaporization prostatectomy (PVP) and transurethral resection of the prostate (TURP) in reducing the volume of prostate and relieving the obstruction in men with benign prostatic hyperplasia (BPH) on non-randomized controlled design.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
86
Inclusion Criteria
  • Symptomatic BPH
  • International Score Prostate Symptom (IPSS) of 13 or greater
  • prostate volume of 30 to 100 ML
  • Peak urinary flow rate (Qmax) less than 15 mL/s with a voided volume of >125 mL and a PVR <350mL
  • Able to give fully informed consent
Exclusion Criteria
  • Subjects with histological diagnosis of prostate cancer
  • Subjects with history of chronic urinary retention
  • Subjects with urethral stricture,
  • Subjects with bladder neck contracture
  • Subjects with urinary tract infection
  • Subjects with prostate volume on TRUS of >100 mL
  • Subjects with suspected neurogenic bladder dysfunction
  • Subjects who, in the opinion of investigator, are not likely to complete the study for whatever reason

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1photoselective vaporization prostatectomy (PVP)PVP group
2Transurethral resection of the prostateTURP group
Primary Outcome Measures
NameTimeMethod
The changes of bladder outlet obstruction index (BOOI)6months
Secondary Outcome Measures
NameTimeMethod
The changes of Quality of Life (QoL) parameters6, 12 months
The changes of Uroflowmetry (UFM) and Postvoid residual urine(PVR)6, 12 months
The changes of detrusor pressure at maximum flow rate (PdetQmax)parameters6months
The changes of International Prostatic Symptom Scores (IPSS)6, 12 months
The changes of Schafer obstruction grade parameters6months
The changes of prostate volume6, 12 months
postoperative catheterization daysimmediate postoperative period
ComplicationsDuring all study periods
The changes of the hemoglobin and the serum sodium and the serum PSAimmediate postoperative period
The change of IIEF score6, 12 months

Trial Locations

Locations (1)

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath